Ironwood Pharmaceuticals Stock
Price
Target price
€5.80
€5.80
-2.520%
-0.15
-2.520%
€18.80
17.05.24 / Stuttgart Stock Exchange
WKN: A0X789 / Symbol: IRWD / Name: Ironwood Pharms / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ironwood Pharmaceuticals Stock
We can see a decrease in the price for Ironwood Pharmaceuticals. Compared to yesterday it has lost -€0.150 (-2.520%).
With 8 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 5.8 € the target price of 18 € shows a potential of 210.34% for Ironwood Pharmaceuticals which would more than double the current price.
Pros and Cons of Ironwood Pharmaceuticals in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ironwood Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals | -2.520% | -7.200% | -21.088% | -39.896% | -43.137% | -41.117% | - |
| Iovance Biotherapeutics Inc. | 1.380% | -7.525% | -11.439% | 38.319% | 20.569% | -29.851% | - |
| Novocure Ltd | 11.220% | 32.158% | 78.326% | -72.485% | 41.786% | -86.061% | - |
| Fibrogen Inc. | -1.490% | 5.964% | 6.654% | -92.969% | 33.256% | -93.207% | - |
Comments
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target lowered by analysts at Craig Hallum from $18.00 to $14.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IRWD provided by MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for IRWD provided by MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target lowered by analysts at Wells Fargo & Company from $20.00 to $14.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IRWD provided by MarketBeat